Duration of initial antidepressant treatment and subsequent relapse of major depression

Journal of Clinical Psychopharmacology

Volumn 35, Issue 1, 2015, Pages 75-76

  Baldessarini, Ross J ^a,b   Lau, Wai Keat ^c   Sim, Jordan ^c   Sum, Min Yi ^d   Sim, Kang ^c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d INSTITUTE OF MENTAL HEALTH   (Singapore)

Author keywords

Antidepressant; Continuation; Discontinuation; Major depression; Placebo; Stabilization

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; ANTIDEPRESSIVE AGENTS;

HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RELAPSE; REVIEW; RISK ASSESSMENT; TREATMENT DURATION; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; META ANALYSIS; METHODS; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME; TRENDS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME;

EID: 84925784964     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000263     Document Type: Review

References (10)

1. Baldessarini RJ. Chemotherapy in Psychiatry. 3rd ed. New York, NY: Springer Press; 2013.
2. Posternak MA, Solomon DA, Leon AC, et al. The naturalistic course of unipolar major depression in the absence of somatic therapy. J Nerv Ment Dis. 2006;194:324-329.
3. Kim KH, Lee SM, Paik JW, et al. Effects of continuous antidepressant treatment during the first 6 months on relapse or recurrence of depression. J Affect Disord. 2011;132:121-129.
4. Prien RF,KupferDJ. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry. 1986;143:18-23.
5. Spijker J, de Graaf R, Bijl RC, et al. Duration of major depressive episodes in the general popuation. Br J Psychiatry. 2002;181:208-213.
6. Baldessarini RJ, Tondo L, Ghiani C, et al. Illness risk following rapid versus gradual discontinuation of antidepressants. Am J Psychiatry. 2010; 167:934-941.
7. Whiteford HA, Harris MG, McKeon G, et al. Estimating remission from untreated major depression: systematic review and meta-analysis. Psychol Med. 2013;43:1569-1685.
8. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: systematic review. Lancet. 2003;361:653-662.
9. Borges S, Chen Y-F, Laughren TP, et al. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration, J Clin Psychiatry. 2014;75:205-214.
10. Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry. 1998;5:293-306.